Related Experiment Videos
HIV-associated dementia, mitochondrial dysfunction, and oxidative stress
Victor Valcour1, Bruce Shiramizu
1NeuroAIDS Specialized Neuroscience Research Program, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA. vvalcour@hawaii.edu
Mitochondrion
|August 27, 2005
Summary
Advances in HIV treatment have altered HIV neuroepidemiology, highlighting mitochondrial toxicity and oxidative stress as key factors in cognitive decline for HIV-1-infected individuals. Further research may reveal new therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Significant progress has been made in understanding HIV-related neurological disease.
- HIV treatment advancements have reshaped HIV care, impacting neuroepidemiology and neuropathogenesis.
- Widespread antiretroviral (ARV) medication use has increased awareness of mitochondrial toxicity, oxidative stress, and metabolic issues linked to cognitive impairment.
Purpose of the Study:
- To review the impact of HIV treatment on neuroepidemiology and neuropathogenesis.
- To explore the role of oxidative stress in cognitive disorders among HIV-1-infected individuals.
- To identify potential therapeutic targets for HIV-associated cognitive impairment.
Main Methods:
- Literature review of research on HIV pathogenesis and neurological disease.
- Analysis of the effects of antiretroviral therapy on HIV neuroepidemiology.
- Discussion of the sources and consequences of oxidative stress in HIV-1 infection.
Main Results:
- HIV treatment has led to changes in the presentation and understanding of neurological complications.
- Oxidative stress, stemming from direct HIV-1 effects, immune activation, and comorbidities, is a significant factor in cognitive dysfunction.
- Mitochondrial toxicity and metabolic abnormalities are increasingly recognized consequences of ARV use.
Conclusions:
- Continued research into oxidative stress mechanisms is crucial for developing effective interventions.
- Understanding the evolving neuropathogenesis of HIV is essential for improving patient outcomes.
- Novel therapeutic strategies targeting oxidative stress pathways may offer benefits for individuals with HIV-associated cognitive disorders.